Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid (Q35760077)

10 August 2017

title

Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid (English)

1 reference

https://api.crossref.org/works/10.1128/AAC.25.5.633

10 August 2017

1 reference

1 reference

3 September 2023

Jones RN

1 reference

10 August 2017

Thornsberry C

1 reference

10 August 2017

Barry AL

1 reference

10 August 2017

Ayers LW

1 reference

10 August 2017

Gerlach EH

1 reference

10 August 2017

H. M. Sommers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6233935

3 September 2023

language of work or name

English

0 references

publication date

1 May 1984

1 reference

full work available at URL

10 August 2017

https://europepmc.org/articles/PMC185603

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6233935

https://europepmc.org/articles/PMC185603?pdf=render

3 September 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6233935

https://journals.asm.org/doi/pdf/10.1128/AAC.25.5.633

3 September 2023

1 reference

https://api.crossref.org/works/10.1128/AAC.25.5.633

Antimicrobial Agents and Chemotherapy

3 September 2023

published in

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

633-637

1 reference

In vitro activity of ciprofloxacin (Bay o 9867)

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185603

Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185603

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185603

Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185603

Pharmacokinetics and tissue penetration of ciprofloxacin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185603

Norfloxacin (MK-0366, AM-715): In vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185603

In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185603

In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid

12 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6233935

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.25.5.633

1 reference

10 August 2017

1 reference

10 August 2017

1 reference